Capital formation challenges in the industry have forced many biotech companies to halt projects, lay off staff or shutdown all together. Our analysis shows that the industry is approximately one-quarter smaller than it was in 2008.
|
November 10, 2009
|
November 6, 2009
|
September 21, 2009
|
September 21, 2009
|
|
September 21, 2009
|
September 21, 2009
|
September 21, 2009
|
September 21, 2009
|